# Pre-doctoral Training Program in Molecular Therapeutics > **NIH NIH T32** · CASE WESTERN RESERVE UNIVERSITY · 2022 · $312,217 ## Abstract The global objective of the NIH-funded Molecular Therapeutics Training Program (MTTP) is to provide highly qualified predoctoral students with the knowledge base and research skills to begin independent investigative and teaching careers in the pharmacological sciences. Rapid advances in biotechnology coupled to the ever- expanding development of new and repurposed therapeutics has created a growing need for highly qualified scientists with core training in the principles and practice of pharmacology. The MTTP has had sustained excellent outcomes and an excess of excellent training grant eligible predoctoral students. Therefore, support is requested for an expansion of the program from four to six predoctoral positions for all years. The goal of the program is to develop professional pharmacologists with the maturity to address new research questions through creativity and collaboration and to communicate their findings to a wide audience documented by publications in premier scientific journals and effective communication with the lay public. We expect our graduates to be fully capable of contributing to the design and evaluation of therapeutic strategies in a range of careers. The MTTP provides a uniform conceptual framework and research environment through which students obtain the PhD degree in Pharmacology at Case Western Reserve University (CWRU). Designed with a three-tiered progression, the MTTP first establishes a didactic foundation in cell and molecular biology coupled with research rotations to facilitate mentor selection. Secondly, a foundation in molecular and physiological pharmacology is achieved via an intensive two-part core course which emphasizes both quantitative analysis and disease- focused study of drugs. Thirdly, students specialize via advanced courses and thesis research. In addition, rigor and reproducibility is a longitudinal component of the curriculum, which emphasizes unbiased experimental approaches that take into account group size, blinded experiments, and sex as a biological variable. These steps ensure that the importance of rigor and reproducibility is at the forefront from year 1 through preparation and defense of the thesis. The thirty-eight MTTP faculty preceptors represent six major research centers in Cleveland: CWRU, University Hospitals, the CWRU Comprehensive Cancer Center, the Cleveland Clinic, the Cleveland VA Medical Center, and MetroHealth Medical Center. This rich diversity of research and training settings is accomplished while maintaining a united focus on pharmacology. The interdisciplinary design fosters productive interactions among students and faculty in basic and clinical departments around the common theme of therapeutics. Collectively the MTTP trainers are a highly interactive group of experienced, well-funded investigators, and there are many examples of collaborative scientific interactions among the program faculty. The environment at CWRU is excellent for research and training PhD s... ## Key facts - **NIH application ID:** 10404590 - **Project number:** 5T32GM008803-19 - **Recipient organization:** CASE WESTERN RESERVE UNIVERSITY - **Principal Investigator:** JOHN J MIEYAL - **Activity code:** T32 (R01, R21, SBIR, etc.) - **Funding institute:** NIH - **Fiscal year:** 2022 - **Award amount:** $312,217 - **Award type:** 5 - **Project period:** 2001-07-01 → 2024-06-30 ## Primary source NIH RePORTER: https://reporter.nih.gov/project-details/10404590 ## Citation > US National Institutes of Health, RePORTER application 10404590, Pre-doctoral Training Program in Molecular Therapeutics (5T32GM008803-19). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10404590. Licensed CC0. --- *[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*